<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>2794-1140</journal-id>
<journal-title><![CDATA[Pharmaceutical Care España]]></journal-title>
<abbrev-journal-title><![CDATA[Pharm Care Esp.]]></abbrev-journal-title>
<issn>2794-1140</issn>
<publisher>
<publisher-name><![CDATA[Fundación Pharmaceutical Care España]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S2794-11402025000100609</article-id>
<article-id pub-id-type="doi">10.60103/phc.v27.e881</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Estudio de la efectividad de la intervención farmacéutica en la mejora de la adherencia terapéutica en pacientes con asma y EPOC]]></article-title>
<article-title xml:lang="en"><![CDATA[Study of the effectiveness of pharmaceutical intervention in improving therapeutic adherence in patients with asthma and COPD]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ochogavía-Oliver]]></surname>
<given-names><![CDATA[Caterina]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Solà-Busquets]]></surname>
<given-names><![CDATA[Laia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Colegio Oficial de Farmacéuticos de las Islas Baleares Servicios Profesionales Farmacéuticos Asistenciales ]]></institution>
<addr-line><![CDATA[Palma ]]></addr-line>
<country>España</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Colegio Oficial de Farmacéuticos de las Islas Baleares Área de Formación ]]></institution>
<addr-line><![CDATA[Palma ]]></addr-line>
<country>España</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>00</month>
<year>2025</year>
</pub-date>
<volume>27</volume>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S2794-11402025000100609&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S2794-11402025000100609&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S2794-11402025000100609&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN Introducción: Los fármacos administrados por vía inhalatoria son los recomendados para el tratamiento de enfermedades respiratorias, pero presentan dificultades en su manejo y la adherencia terapéutica con estos medicamentos es inferior al 50%, lo que nos lleva a estudiar la efectividad de la intervención del farmacéutico comunitario para mejorar el proceso de uso de estos dispositivos, aumentar la adherencia terapéutica y el control de estas patologías. Método: Estudio prospectivo no controlado no aleatorizado. Mediante el Servicio de Adherencia Terapéutica se evaluó la adherencia con el test de Morisky-Green, el control del asma con el cuestionario ACT y la determinación del Flujo Espiratorio Máximo (FEM), el control de la EPOC con el cuestionario CAT y la calidad de vida percibida con la Escala Visual Analógica (EVA), en dos visitas. Resultados: Del total de pacientes incluidos en el estudio (n=80), el 62,5% presentaban asma y el 37,5% EPOC. En asma, los pacientes adherentes aumentaron del 30,0% al 68,0%, obtuvieron una mejoría en el test ACT de 1,9 puntos (DE: 3,2) y el 80,0% mejoró o mantuvo su calidad de vida. En EPOC, los pacientes adherentes aumentaron del 16,7% al 53,3%, obtuvieron una mejoría en el test CAT de -2,4 puntos (DE: 6,0) y el 83,3% mejoró o mantuvo su calidad de vida. Conclusiones: La prestación del Servicio de Adherencia Terapéutica ha incrementado un 35,0% el número de pacientes adherentes y ha mostrado un impacto positivo en el control clínico de ambas patologías y en la calidad de vida.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT Introduction: Drugs administered by inhalation are recommended for the treatment of respiratory diseases, but they present difficulties in their management and therapeutic adherence with these drugs is less than 50%, which leads us to study the effectiveness of the intervention of the community pharmacist to improve the process of using these devices, increase therapeutic adherence and control of these pathologies. Method: A non-controlled, non-randomized prospective study. The Therapeutic Adherence Service assessed adherence with the Morisky-Green test, asthma control with the ACT questionnaire, and the measurement of Peak Expiratory Flow (PEF), COPD control with the CAT questionnaire, and perceived quality of life with the Visual Analog Scale (VAS), in two visits. Results: Of the total patients included in the study (n=80), 62.5% had asthma and 37.5% had COPD. Among asthma patients, adherence increased from 30.0% to 68.0% with a 1.9-point improvement (SD: 3.2) in the ACT test, and 80.0% either improved or maintained their quality of life. Among COPD patients, adherence increased from 16.7% to 53.3%, with a -2.4-point improvement (SD: 6.0) in the CAT test, and 83.3% either improved or maintained their quality of life. Conclusions: The provision of the Therapeutic Adherence Service increased the number of adherent patients by 35.0% and showed a positive impact on the clinical control of both conditions and on quality of life.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[asma]]></kwd>
<kwd lng="es"><![CDATA[EPOC, adherencia terapéutica]]></kwd>
<kwd lng="es"><![CDATA[farmacéutico comunitario]]></kwd>
<kwd lng="es"><![CDATA[inhalador]]></kwd>
<kwd lng="en"><![CDATA[asthma]]></kwd>
<kwd lng="en"><![CDATA[COPD]]></kwd>
<kwd lng="en"><![CDATA[therapeutic adherence]]></kwd>
<kwd lng="en"><![CDATA[community pharmacist]]></kwd>
<kwd lng="en"><![CDATA[inhaler]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lestón]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uso correcto de los dispositivos de inhalación en asma y EPOC]]></article-title>
<source><![CDATA[Butlletí de Prevenció d&#8217;Errors de Medicació de Catalunya]]></source>
<year>2022</year>
<volume>20</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaztelurrutia]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Seguimiento del asma desde la farmacia comunitaria]]></article-title>
<source><![CDATA[Argibideak]]></source>
<year>2022</year>
<volume>32</volume>
<numero>4</numero>
<issue>4</issue>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Gaztelurrutia]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[EPOC: seguimiento y cribado desde la farmacia, ¿qué se puede hacer?]]></article-title>
<source><![CDATA[Argibideak]]></source>
<year>2022</year>
<volume>32</volume>
<numero>2</numero>
<issue>2</issue>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="">
<collab>GEMA 5.3</collab>
<source><![CDATA[Guía Española para el manejo del Asma]]></source>
<year></year>
</nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Armour]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Reddel]]></surname>
<given-names><![CDATA[HK]]></given-names>
</name>
<name>
<surname><![CDATA[Lemay]]></surname>
<given-names><![CDATA[KS]]></given-names>
</name>
<name>
<surname><![CDATA[Saini]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[LD]]></given-names>
</name>
<name>
<surname><![CDATA[Bosnic-Anticevich]]></surname>
<given-names><![CDATA[SZ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trial]]></article-title>
<source><![CDATA[J Asthma]]></source>
<year>2013</year>
<volume>50</volume>
<page-range>302-9</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Fathima]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Naik-Panvelkar]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Saini]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Armour]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The role of community pharmacists in screening and subsequent management of chronic respiratory diseases: a systematic review]]></article-title>
<source><![CDATA[Pharmacy Pract (Granada)]]></source>
<year>2013</year>
<volume>11</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>228-45</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Basheti]]></surname>
<given-names><![CDATA[IA]]></given-names>
</name>
<name>
<surname><![CDATA[Reddel]]></surname>
<given-names><![CDATA[HK]]></given-names>
</name>
<name>
<surname><![CDATA[Armour]]></surname>
<given-names><![CDATA[CL]]></given-names>
</name>
<name>
<surname><![CDATA[Bosnic-Anticevich]]></surname>
<given-names><![CDATA[SZ]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Improved asthma outcomes with a simple inhaler technique intervention by community pharmacists]]></article-title>
<source><![CDATA[J Allergy Clin Immunol]]></source>
<year>2007</year>
<volume>119</volume>
<page-range>1537-8</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giraud]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Allaert]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Roche]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inhaler technique and asthma: feasibility and acceptability of training by pharmacists]]></article-title>
<source><![CDATA[Respir Med]]></source>
<year>2011</year>
<volume>105</volume>
<page-range>1815-22</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Mubarak]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Hatah]]></surname>
<given-names><![CDATA[EM]]></given-names>
</name>
<name>
<surname><![CDATA[Khan]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
<name>
<surname><![CDATA[Zin]]></surname>
<given-names><![CDATA[CS]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A systematic review and meta-analysis of the impact of collaborative practice between community pharmacist and general practitioner on asthma management]]></article-title>
<source><![CDATA[J Asthma Allergy]]></source>
<year>2019</year>
<volume>12</volume>
<page-range>109-53</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Giraud]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Allaert]]></surname>
<given-names><![CDATA[FA]]></given-names>
</name>
<name>
<surname><![CDATA[Roche]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Inhaler technique and asthma: feasibility and acceptability of training by pharmacists]]></article-title>
<source><![CDATA[Respir Med]]></source>
<year>2011</year>
<volume>105</volume>
<numero>12</numero>
<issue>12</issue>
<page-range>1815-22</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[García]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Gastelurrutia]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Malet]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Peiró]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Pérez]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Saez]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Diseño, evaluación del impacto e implantación de un servicio profesional de adherencia terapéutica desde el ámbito de la farmacia comunitaria]]></source>
<year>2019</year>
<publisher-name><![CDATA[Consejo General de Colegios Oficiales de Farmacéuticos]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="">
<source><![CDATA[Global Initiative for Chronic Obstructive Lung Disease]]></source>
<year>2023</year>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<collab>Foro de Atención Farmacéutica-Farmacia Comunitaria (Foro AF-FC), panel de expertos</collab>
<source><![CDATA[Guía práctica para los Servicios Profesionales Farmacéuticos Asistenciales desde la Farmacia Comunitaria]]></source>
<year>2024</year>
<publisher-loc><![CDATA[Madrid ]]></publisher-loc>
<publisher-name><![CDATA[Consejo General de Colegios Oficiales de Farmacéuticos]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Morisky]]></surname>
<given-names><![CDATA[DE]]></given-names>
</name>
<name>
<surname><![CDATA[Green]]></surname>
<given-names><![CDATA[LW]]></given-names>
</name>
<name>
<surname><![CDATA[Levine]]></surname>
<given-names><![CDATA[DM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Concurrent and predictive validity of a self-reported measure of medication adherence]]></article-title>
<source><![CDATA[Med Care]]></source>
<year>1986</year>
<volume>24</volume>
<page-range>67-74</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vega]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Badia]]></surname>
<given-names><![CDATA[X]]></given-names>
</name>
<name>
<surname><![CDATA[Badiola]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Lopez-Vina]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Olaguibel]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Picado]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation of the Spanish version of the Asthma Control Test (ACT)]]></article-title>
<source><![CDATA[J Asthma]]></source>
<year>2007</year>
<volume>44</volume>
<numero>10</numero>
<issue>10</issue>
<page-range>867-72</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Stallberg]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Nokela]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Ehrs]]></surname>
<given-names><![CDATA[PO]]></given-names>
</name>
<name>
<surname><![CDATA[Hjemdal]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Jonsson]]></surname>
<given-names><![CDATA[EW]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Validation of the clinical COPD Questionnaire (CCQ) in primary care]]></article-title>
<source><![CDATA[Health Qual Life Outcomes]]></source>
<year>2009</year>
<volume>7</volume>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carpenter]]></surname>
<given-names><![CDATA[JC]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A meta-analysis of the effectiveness of health belief model variables in predicting behavior]]></article-title>
<source><![CDATA[Health Communication]]></source>
<year>2010</year>
<volume>25</volume>
<numero>8</numero>
<issue>8</issue>
<page-range>661-9</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
